PREVENTION CENTER SHARED RESOURCE (PCSR) The goal of the Prevention Center Shared Resource (PCSR) is to facilitate transdisciplinary, collaborative research within the Consortium, focused on better understanding the contributions of behavior/lifestyle modification, nutrition, physical activity, and obesity to cancer development, prognosis, and survivorship. Centrally located at Fred Hutch (FH), the PCSR accomplishes this by providing Consortium investigators access to well-trained staff and a full-service research facility (over 10,000 nsf) that contains a Research Clinic (RC), Exercise Research Center (ERC), and Human Nutrition Lab (HNL). The RC is staffed with medical personnel who can perform clinical assessments, collect biospecimens (including various biopsies), and obtain detailed anthropometry. The ERC conducts exercise training and testing, including VO2 max, spirometry, and indirect calorimetry. Trained exercise physiologists are available to help investigators design tailored exercise programs and to oversee exercise sessions for study participants. The HNL provides comprehensive support for the conduct of human feeding studies as well as the food component of behavioral and community nutrition intervention studies. Services include study diet design, food production and delivery, meal service, data collection, and study participant management and monitoring according to diet intake protocols. The PCSR also provides training and certification for technical staff and serves as a support resource and training facility for investigators, post-doctoral and clinical fellows, and students interested in exercise science and nutrition research. Given the increasing number of individuals in the US affected by cancer, it is of great importance to identify causes of cancer that are preventable and ways to improve the quality of life among cancer survivors. The long-term goal of the PCSR is to maintain itself as a unique, cutting-edge resource for the Consortium, to facilitate advances in our knowledge of the behavioral/lifestyle, nutritional, physical activity, and obesity-related contributors to cancer development, prognosis, and survivorship.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA015704-45
Application #
9853658
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-01-01
Budget End
2020-12-31
Support Year
45
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Poudel, Kumud R; Roh-Johnson, Minna; Su, Allen et al. (2018) Competition between TIAM1 and Membranes Balances Endophilin A3 Activity in Cancer Metastasis. Dev Cell 45:738-752.e6
Holly, Mayumi K; Smith, Jason G (2018) Adenovirus infection of human enteroids reveals interferon sensitivity and preferential infection of goblet cells. J Virol :
Cheng, Heather H (2018) The resounding effect of DNA repair deficiency in prostate cancer. Urol Oncol 36:385-388
Bar, Merav; Flowers, Mary E D; Storer, Barry E et al. (2018) Reversal of Low Donor Chimerism after Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion: A Prospective Phase II Multicenter Trial. Biol Blood Marrow Transplant 24:308-313
Eaton, Keith D; Romine, Perrin E; Goodman, Gary E et al. (2018) Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility. J Thorac Oncol 13:649-659
Graves, Scott S; Parker, Maura H; Stone, Diane et al. (2018) Anti-Inducible Costimulator Monoclonal Antibody Treatment of Canine Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant 24:50-54
Gauthier, Jordan; Turtle, Cameron J (2018) Insights into cytokine release syndrome and neurotoxicity after CD19-specific CAR-T cell therapy. Curr Res Transl Med 66:50-52
Amundsen, Susan K; Smith, Gerald R (2018) The RecB helicase-nuclease tether mediates Chi hotspot control of RecBCD enzyme. Nucleic Acids Res :
Méndez, Eduardo; Rodriguez, Cristina P; Kao, Michael C et al. (2018) A Phase I Clinical Trial of AZD1775 in Combination with Neoadjuvant Weekly Docetaxel and Cisplatin before Definitive Therapy in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res 24:2740-2748
Buckley, Sarah A; Percival, Mary-Elizabeth; Othus, Megan et al. (2018) A comparison of patients with acute myeloid leukemia and high-risk myelodysplastic syndrome treated on versus off study. Leuk Lymphoma :1-7

Showing the most recent 10 out of 1267 publications